Success Story: EB-1A Approved After RFE for a Postdoctoral Scholar from Lebanon in Just Over 3 Months
Client’s Testimonial:
“I appreciate the support I received from the North America Immigration Law Group during my EB-1A process. After receiving an RFE, their team helped organize and present my research contributions clearly and effectively.
My case was approved under premium processing in a little over three months. The team was responsive and professional throughout the process.”
On January 28th, 2026, we received another EB-1A (Alien of Extraordinary Ability) approval for a Postdoctoral Scholar in the Field of AI and Machine Learning in Clinical Medicine (Approval Notice).
General Field: AI and Machine Learning in Clinical Medicine
Position at the Time of Case Filing: Postdoctoral Scholar
Country of Origin: Lebanon
State of Residence at the Time of Filing: California
Approval Notice Date: January 28th, 2026
Processing Time: 3 months, 18 days (Premium Processing Requested)
Case Summary:
North America Immigration Law Group (Chen Immigration Law Associates) secured EB-1A approval for a postdoctoral scholar specializing in AI and machine learning in clinical medicine. The petition was filed with a request for Premium Processing. Although USCIS issued a Request for Evidence (RFE), we successfully secured the case's approval in just over 3 months.
The client's work focuses on bioinformatics, computationally-driven healthcare research, and effective treatment personalization, with particular expertise in improving neurosurgical care. While the underlying computational science is complex, our strategic objective was straightforward: translate deep technical originality into clear evidence of field-wide reliance, sustained recognition, and credible ongoing work in the United States.
Research Excellence and Expert Validation
The client's research was supported by objective validation through publication in the most prestigious journals in the field and 8 recommendation letters from experts.
One expert noted in a support letter:
"Together, [The Client]’s findings offer an array of advanced clinical tools and techniques to further improve health outcomes, offering immense benefits for medical clinicians that necessitate efficient treatment to reduce operating costs and to mitigate hospital readmissions."
Evidence of Independent Influence and Peer RecognitionWith an M.D. and a B.Sc. in biology, the client is a highly qualified advanced degree scientist with extensive research experience. A strong EB-1A case does not rely on one type of proof. It reads as a converging record, with different categories of evidence corroborating the same conclusion: that the beneficiary's work is influencing the field beyond their immediate environment.
In this matter, the client's credentials showed that pattern clearly:
- 32 peer-reviewed journal articles (6 first- and co-first-authored), 1 accepted journal article, 2 preprints, and 1 first-authored book chapter
- Multiple highly cited publications, including at least 10 articles ranking among the most cited for their publication years. The client is recognized as one of the top 1% most highly cited authors publishing on computational intelligence topics.
- Recognition through 6 peer reviews for distinguished journals
The Result
We congratulate the client on this excellent outcome and are honored that our firm could help present a sophisticated AI and clinical medicine research record in a clear, adjudicator-readable form, especially under RFE scrutiny.